UK markets close in 7 hours 20 minutes
  • FTSE 100

    7,218.91
    -15.12 (-0.21%)
     
  • FTSE 250

    22,955.55
    -28.69 (-0.12%)
     
  • AIM

    1,231.04
    +1.94 (+0.16%)
     
  • GBP/EUR

    1.1854
    +0.0069 (+0.58%)
     
  • GBP/USD

    1.3747
    +0.0070 (+0.51%)
     
  • BTC-GBP

    45,123.11
    +920.55 (+2.08%)
     
  • CMC Crypto 200

    1,452.24
    +77.02 (+5.60%)
     
  • S&P 500

    4,471.37
    +33.11 (+0.75%)
     
  • DOW

    35,294.76
    +382.16 (+1.09%)
     
  • CRUDE OIL

    83.26
    +0.98 (+1.19%)
     
  • GOLD FUTURES

    1,764.40
    -3.90 (-0.22%)
     
  • NIKKEI 225

    29,025.46
    +474.56 (+1.66%)
     
  • HANG SENG

    25,339.85
    +377.25 (+1.51%)
     
  • DAX

    15,517.56
    -69.80 (-0.45%)
     
  • CAC 40

    6,663.36
    -64.16 (-0.95%)
     

RHÖN-KLINIKUM Aktiengesellschaft: Adjustment of Guidance for the Financial Year 2021

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Change in Forecast
RHÖN-KLINIKUM Aktiengesellschaft: Adjustment of Guidance for the Financial Year 2021

08-Oct-2021 / 15:57 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of Inside Information according to Article 17 Market Abuse Regulation (MAR)


Bad Neustadt a. d. Saale, 8 October 2021

Adjustment of Guidance for the Financial Year 2021

Due to the positive development of the business in the first nine months of the financial year 2021 the management board of RHÖN-KLINIKUM Aktiengesellschaft decided today to adjust the current guidance for the Earnings before interest, taxes, depreciation and amortisation (EBITDA) for the financial year 2021 (between € 72.5 million and € 82.5 million). For the financial year 2021 the management board of the Company now expects an EBITDA between € 92 million and € 102 million.

The guidance for the revenues in the amount of € 1.4 billion within a range of +/- 5 % remains unchanged.

This guidance reflects the regulatory legislative interventions, such as the German regulation for the threshold for nursing staff (Pflegepersonaluntergrenzen-Verordnung - PpUGV) and the German nursing staff reinforcement act (Pflegepersonal-Stärkungsgesetz - PpSG), which have become even tighter. In addition, it should be noted that the guidance is subject to uncertainties in connection with the course of the COVID-19 pandemic and any regulatory legislation affecting the remuneration structure in 2021.


Contact:

RHÖN-KLINIKUM AG
Group Head of Accounting, Tax, Controlling, Finance and Investor Relations
Igor Levit
T. +49 9771 65-12210 | igor.levit@rhoen-klinikum-ag.com

RHÖN-KLINIKUM AG
Head of Investor Relations and Treasury
Julian Schmitt
T. +49 9771 65-12250 | julian.schmitt@rhoen-klinikum-ag.com


RHÖN-KLINIKUM AG | Schlossplatz 1 | D-97616 Bad Neustadt a. d. Saale

08-Oct-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:

English

Company:

RHÖN-KLINIKUM Aktiengesellschaft

Salzburger Leite 1

97616 Bad Neustadt a.d.Saale

Germany

Phone:

+49 (0)9771 - 65-0

Fax:

+49 (0)9771 - 97 467

E-mail:

rka@rhoen-klinikum-ag.com

Internet:

www.rhoen-klinikum-ag.com

ISIN:

DE0007042301

WKN:

704230

Listed:

Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange

EQS News ID:

1239569


 

End of Announcement

DGAP News Service

show this
show this
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting